NCR Atleos Corporation
NCR Atleos Corporation (NATL) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for NCR Atleos Corporation (NATL), covering cash flow, earnings, and balance sheets.
NCR Atleos Corporation (NATL) Income Statement & Financial Overview
Review NCR Atleos Corporation NATL income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $980.00M | $1.11B | $1.08B | $1.08B |
| Cost of Revenue | $745.00M | $811.00M | $816.00M | $854.00M |
| Gross Profit | $235.00M | $297.00M | $262.00M | $227.00M |
| Gross Profit Ratio | $0.24 | $0.27 | $0.24 | $0.21 |
| R&D Expenses | $17.00M | $19.00M | $16.00M | $14.00M |
| SG&A Expenses | $119.00M | $83.00M | $122.00M | $132.00M |
| Operating Expenses | $139.00M | $146.00M | $143.00M | $134.00M |
| Total Costs & Expenses | $884.00M | $948.00M | $959.00M | $988.00M |
| Interest Income | $0.00 | $4.00M | -$3.00M | $2.00M |
| Interest Expense | $67.00M | $77.00M | $79.00M | $85.00M |
| Depreciation & Amortization | $69.00M | $69.00M | $74.00M | $71.00M |
| EBITDA | $162.00M | $220.00M | $190.00M | $164.00M |
| EBITDA Ratio | $0.17 | $0.20 | $0.18 | $0.15 |
| Operating Income | $96.00M | $151.00M | $119.00M | $107.00M |
| Operating Income Ratio | $0.10 | $0.14 | $0.11 | $0.10 |
| Other Income/Expenses (Net) | -$70.00M | -$77.00M | -$82.00M | -$75.00M |
| Income Before Tax | $26.00M | $74.00M | $37.00M | $32.00M |
| Income Before Tax Ratio | $0.03 | $0.07 | $0.03 | $0.03 |
| Income Tax Expense | $10.00M | $25.00M | $14.00M | $4.00M |
| Net Income | $17.00M | $46.00M | -$57.00M | $29.00M |
| Net Income Ratio | $0.02 | $0.04 | -$0.05 | $0.03 |
| EPS | $0.23 | $0.63 | -$0.79 | $0.40 |
| Diluted EPS | $0.23 | $0.61 | -$0.77 | $0.39 |
| Weighted Avg Shares Outstanding | $73.10M | $72.50M | $72.30M | $72.20M |
| Weighted Avg Shares Outstanding (Diluted) | $75.20M | $75.00M | $74.50M | $73.70M |
Over the past four quarters, NCR Atleos Corporation demonstrated steady revenue growth, increasing from $1.08B in Q2 2024 to $980.00M in Q1 2025. Operating income reached $96.00M in Q1 2025, maintaining a consistent 10% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $162.00M, reflecting operational efficiency. Net income dropped to $17.00M, with EPS at $0.23. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan